Oxycodone Vaccine Passes Early Tests

In preclinical testing, a new vaccine hindered the often-abused prescription opioids oxycodone and hydrocodone from entering the brain and suppressed one of the drugs’ signature central nervous system (CNS) effects. According to vaccinologists Dr. Marco Pravetoni, Dr. Paul Pentel, and colleagues at the University of Minnesota, the findings warrant continued development of the vaccine as a potential aid in the treatment of oxycodone and hydrocodone abuse and dependence.


Source: National Institute on Drug Abuse – May 28, 2013